|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.05 USD | -1.28% |
|
+7.21% | - |
| 07-13 | BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27 | MT |
| 07-13 | Alamar Biosciences Partners With Research Universities on Neurodegenerative Biomarker Project | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.28% | +7.21% | +22.95% | - | - | - | - | - | - | 1.87B | |
| +1.05% | +3.38% | +13.79% | +1.30% | -7.83% | +25.56% | +0.89% | +4.56% | +238.60% | 198B | |
| -6.78% | -11.19% | -7.68% | -18.77% | -32.99% | -26.52% | +7.20% | +19.20% | +405.55% | 134B | |
| -0.55% | +2.50% | +10.52% | +0.22% | -13.05% | +0.66% | -17.25% | -27.91% | +146.11% | 141B | |
| -4.52% | -5.89% | -9.12% | -33.20% | -55.29% | -59.14% | -19.61% | -0.26% | +79.27% | 63.36B | |
| -1.85% | -4.99% | +5.85% | +15.20% | +5.68% | +15.09% | -3.52% | -15.64% | +152.52% | 51.87B | |
| -0.15% | -2.72% | -0.98% | -10.45% | -23.66% | -25.44% | -33.65% | -36.07% | - | 43.77B | |
| +0.87% | +3.10% | +4.13% | +12.30% | -0.64% | +12.59% | +12.90% | -9.04% | +188.89% | 38.18B | |
| +0.85% | +0.39% | +5.87% | +13.72% | -0.91% | +23.74% | +39.01% | +1.28% | +152.15% | 36.96B | |
| -5.59% | -4.98% | -5.40% | -17.42% | -24.82% | -17.18% | -24.64% | - | - | 28.05B | |
| +0.61% | -0.29% | +18.78% | +46.72% | +45.78% | +94.05% | +2.16% | -58.52% | +29.86% | 28.93B | |
| -2.77% | -12.17% | -0.91% | -16.33% | -19.87% | -24.04% | -13.20% | -22.60% | +196.48% | 27.84B | |
| +0.87% | -3.74% | +0.48% | -6.15% | -0.22% | +11.49% | +18.69% | -36.01% | +9.52% | 25.07B | |
| +0.20% | +1.30% | -7.34% | -12.78% | -26.51% | -35.50% | -53.57% | -69.37% | - | 24.99B | |
| +0.48% | -.--% | -.--% | -.--% | +2.04% | +17.63% | -5.37% | +12.51% | +108.08% | 16.97B | |
| +0.09% | -0.75% | +11.59% | +18.93% | +14.95% | +12.94% | -9.45% | -26.83% | +98.98% | 12.41B | |
| -2.62% | -1.30% | +3.62% | +8.21% | -11.97% | +5.05% | -21.66% | -21.54% | +81.51% | 11.77B | |
| +1.46% | +2.71% | +10.33% | +49.95% | +27.00% | +38.46% | -19.25% | -25.39% | +141.64% | 9.11B | |
| -3.30% | -25.57% | +4.11% | +25.98% | - | - | - | - | - | 3.98B | |
| +4.97% | +1.43% | +12.37% | -22.90% | -17.44% | +30.60% | - | - | - | 4.08B | |
| Average | -0.63% | -1.51% | +4.65% | +2.87% | -7.76% | +5.56% | -8.25% | -19.48% | +144.94% | 45.15B | |
| Weighted average by Cap. | -1.05% | -1.42% | +4.24% | -2.55% | -13.90% | +0.94% | -5.32% | -10.07% | +201.07% |
- Stock Market
- Stocks
- ALMR Stock
- Sector Alamar Biosciences, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
